Compare Dover Corp (DOV) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs McKesson Corporation — how do they compare? Dover Corp trades at $208.79 (market cap $28.07B), while McKesson Corporation trades at $899.6 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 3.7× Dover Corp's market cap, and Dover Corp pays the higher dividend (1.01%). Which is the better fit depends on your goals.
| DOV | MCK | |
|---|---|---|
Market Cap | $28.07B | $105.14B |
Sector | Industrials | Health |
52-Week High | $233.31 | $995.69 |
52-Week Low | $161.16 | $659.01 |
Enterprise Value | $29.58B | $111.67B |
Dividend Yield | 1.01% | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
